Receptors for hematopoietic cytokines possess intrinsic tyrosine-kinases or are associated with tyrosine-kinases; interactions between metabolic pathways activated by tyrosinekinases and heterotrimeric G proteins are suspected, but not yet proven. To investigate whether alteration of G protein function affects signal transduction of hematopoietic cytokines, we expressed mutant GI, proteins in BAC 1.2F5 cells, a murine macrophage cell line that is dependent from monocyte-macrophage colony-stimulating factor (CSF 1) for its proliferation. Mutations made in a subunits constitutively activate (S2-wo5L) or inactivate (a12-G204A) Gi2 heterotrimers. We show that expression of ai2-Q205L in BAC 1.2F5 cells does not induce independence from CSF 1, but reduces the cells' requirement in CSF 1, shortens the length of the
G I phase and the cell doubling time in response to CSF 1, and protects cells from death by apoptosis induced by CSF 1 withdrawal, exposure to H202 or heat shock, but not mitoxantrone. More importantly, expression of ai2-G204A, a dominant negative mutant, inhibits BAC 1.2F5 cell proliferation in response to CSF 1, increases the length of the G I phase and the cell doubling time, and accelerates apoptotic cell death after withdrawal of CSF 1, exposure to H,O, or heat shock. We conclude that the metabolic pathways regulated by Gi2 proteins and CSF 1 tyrosine-kinase receptors converge on a common effector necessary for the regulation of macrophage survival and proliferation. 0 1995 by The American Society of Hematology.
seven transmembrane domain receptor family: they are made of several chains, identical or distinct, associated with tyrosine-kinases." The CSF 1 receptor, which is encoded by the c-fms protooncogene, is a single transmembrane domain protein with intrinsic tyrosine-kinase activity.",'' Inhibition of CSF 1 biochemical and biologic effects by PT is well documented.'"' CSF 1 regulates terminal differentiation of hematopoietic progenitors into monocytes and macrophages, survival of macrophages and duration of the G1 and S phases of cell cycle,'"'' and also stimulates specific macrophage functions. Signal transduction of CSF 1 involves tyrosine phosphorylation of a number of proteins, including the receptor itself and phosphoinositol 3' kinase, stimulation of Na+ influx, and activation of phosphoinositol3' kinase and phosphatidyl-choline phospholipase C.'o, '8,20 -23 PT inhibits CSF 1 stimulation of Na' influx and phosphatidylcholine phospholipase C a c t i~i t y . " '~~~~ PT inhibits CSF 1 stimulation of myeloid cell proliferation and differentiation, and, in bone marrow macrophages and in fibroblasts expressing c-fms, DNA synthesis is partially or totally inhibited by PT.8,'2, 24 Addition of CSF 1 to monocyte membranes increases the binding of GTP analogs and increases GTPase activity." However, direct evidence of involvement of a PT-sensitive G protein, and determination of its identity, in the signal transduction of CSF 1 and other hematopoietic cytokines, are still missing. Recently, several G proteins (G,,, G,, GI,) were shown to stimulate fibroblast cell growth or transformation.2s-2x EXpression of G, and GI2 in hematopoietic cells is still uncertain; but we know that the PT-sensitive G proteins expressed in myeloid cells are Gi2 and Gi3. Gi2 proteins are ubiquitous and very abundant in myeloid cells. Therefore, to determine whether G protein function affects signal transduction of hematopoietic cytokines, we chose to first study CSF 1 signal transduction, and to express mutant G,, proteins in BAC 1.2F5 cells, a murine macrophage cell line that is strictly dependent on CSF 1 for its survival and proliferation." Because Gi2 proteins are made of three subunits (a, P, 7 ) . they can, in theory, be activated through each subunit, ie, a subunits or P7 complexes. After stimulation of the receptor, (Y subunits bind GTP, become activated, release P y subunits, and specific effectors are activated. P7 subunits form tight complexes, responsible for the attachment of the hetero- For personal use only. on October 31, 2017. by guest www.bloodjournal.org From trimer to the membrane, and also appear to modulate effector f~n c t i o n . '~.~~ a subunits possess an intrinsic GTPase activity and the reaction stops when GTP is hydrolyzed into GDP, allowing reassociation of a and P y subunits and formation of an inactive, heterotrimeric G protein. No activating mutation of /? or y subunits has yet been described, so we can modulate GiZ's activity only through its a subunit. The domains involved in binding GTP are highly conserved among G proteins; several mutations in one of these domains, initially described in a subunits of G, proteins, constitutively activate or inactivate G,. The Q227L mutation decreases the GTPase activity of a, and results in constitutive activation of G,
The G226A mutation prevents a, from undergoing the conformation change necessary to achieve the activated state after binding of GTP.33 Therefore, G, is blocked in the inactive, heterotrimeric state; this last mutation is a dominant negative mutation. 34 The equivalent mutations have been made in ai* subunits with the same effects on the state of activation of aiz: the Q205L mutation constitutively activates ai2 (and Gi2) and the G204A mutation has also proved to be a dominant negative mutant for Gi2.25. 35 We stably expressed the aiz-Q205L and ai2-G204A mutants in BAC 1.2F5 cells and studied the growth characteristics of ai*-transfected cells in response to CSF 1.
MATERIALS AND METHODS
Cell cultures. CSF 1 -dependent BAC 1.2F.5 macrophages were obtained from Dr E. Richard Stanley (Albert Einstein College of Medicine, Bronx, NY).'9.36 The cells were grown in Dulbecco's modified Eagle's medium (DMEM), or RPMI 1640, supplemented with 10% fetal bovine serum and 10% L929 cell-conditioned medium (L929 CM) as a source of murine CSF l.37 L929 CM was prepared as follows: L929 cells were grown to confluency in DMEM with 10% serum, then incubated for 6 days in the presence of fresh medium. Supernatants from these cultures (L929 CM) were centrifuged, filtered, and kept at -20°C until use. Biological activity of 10% L929 CM corresponds approximately to the activity of 400 to 500 u/mL of purified recombinant human CSF 1, a gift from Genetics Institute (Cambridge, MA), used for colony assays.
Cell infections.
Wild type and mutated aIz cDNAs were subcloned into the retroviral expression vector pMV7, as described.25 In this vector, the transcription of cDNAs and the G418 resistance gene are directed by the Moloney murine leukemia virus (MoMuLV) long terminal repeat. Retroviruses encoding wild-type or mutated aiz cDNA were packaged into the Qz and PA317 packaging cell lines. Virus-containing supernatants were harvested and titered on NIH 3T3 cells for G418-resistant colony formation. Infection of BAC 1.2F5 cells with filtered Supernatants containing infectious viruses ( > l @ CFU/mL) was performed in the presence of 8 pg/mL of polybrene. Twenty-four hours after infection, cells were selected for at least 2 weeks in the presence of 1 mg/mL of G418 sulfate. G418-resistant cells were divided into several cell pools. Cells from one cell pool were cloned by limiting dilution in 96-well microtiter culture dishes and expanded. Clones were then grown with or without a source of CSF 1 to study CSF 1 dependence. All other growth studies were done with pools of transfected cells.
Protein analysis. Both G41 8-resistant cell pools and clones were screened by Western blotting for ai2 expression. Confluent cultures were scraped, pelleted and washed three times in 10 mL of phosphate-buffered saline (PBS), pH 7.5.
Cell pellets were frozen (-7OoC), thawed once, and crude membranes were prepared, as previously described.25 Protein concentration was determined by the Bicinchoninic Acid (BCA) method (Pierce) with bovine serum albumin (BSA) used as a standard." A total of 5 pg of membrane proteins were resolved on a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel, transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA) and immunoblotted with the affinity-purified antiserum AS 7, specific for a,z.39 Detection of the antibody-antigen complex was by enhanced chemiluminescence procedure (ECL kit; Boehringer-Mannheim. Mannheim, Germany). Blots were then exposed to X-Omat Kodak films (Eastman Kodak, Rochester, NY) for 1 minute to visualize immunoreactive bands.
mRNA analysis. Cells were grown to half confluency, scraped, pelleted, washed three times with sterile PBS and kept frozen at -70°C. PoIyA+ mRNAs were prepared using Micro-FastTrack mRNA Isolation Kits (Invitrogen, San Diego, CA) according to manufacturer's instructions. After addition of glyoxaVdimethylsulfoxide, polyA+ mRNAs were separated on 1% agarose gels (3 pg/ lane), and transferred to nylon membranes (Hybond-N; Amersham, Les Ulis, France). Membranes were prehybridized for 4 hours at 42°C in 10 mL of 50 mmol/L TRlS pH 7.0 containing 1OX Denhardt's solution, 50% formamide, 1% SDS, 1 moVL NaCl, and 100 pg/mL salmon sperm DNA. Hybridization was performed overnight at 42°C with the random-primed 32P-labeled cDNA probe in 10 mL of the same solution used for prehybridization. The probe used was the entire coding region of rat aiz cDNA. After hybridization, the membranes were washed twice in 2X SSC for 15 minutes at room temperature, once in 0.5X SSC + 0.1% SDS for 30 minutes at 6 5 T , and once in 0 . 2~ SSC + 0.1 % SDS for 30 minutes at 65°C.
Blots were exposed to X-Omat Kodak films. Sizes of mRNA were determined by comparison with the migration of a 0.25-to 9.5-kb RNA ladder standard (BRL, Life Technologies, Eragny, France).
Growth Studies in Monolayer Cultures
Doubling time studies. Cells were plated at a density of 30,000 cells per 30 mm culture dish and grown in RPMI 1640 supplemented with 10% serum and 1% or 5% of L929 CM as a source of CSF 1.
Medium and L929 CM were replaced twice a week. Counts of viable cells (excluding Trypan blue) were determined in triplicate every day from day 1 to day 10. The results obtained were analyzed for exponential doubling time.
Cell survival in the absence of CSF 1. Cells were plated at a density of lo5 cells per 30 mm culture dish, grown in the presence of 10% L929 CM for 24 hours, then washed three times with warm PBS to remove any trace of CSF 1, and 2 mL of fresh RPMI 1640 supplemented with 10% serum (no CSF 1) were added. Cells were fed thereafter every other day with RPMI 1640 supplemented with 10% serum, without CSF 1. Counts of viable cells were assessed by Trypan blue exclusion in triplicate every other day from day 1 to day 12.
Colony assays in collagene. Suspensions of 1,000 cells were mixed in 1 mL of a growth medium containing 25% rat collagene (Jacques Boy, Reims, France), 25% Iscove X 2, 10% serum, and up to 40% Iscove X 1 including, or not, variable amounts of CSF 1 (purified human recombinant CSF 1 or L929 CM), as previously described!'
These semisolid cultures were c a n i d out in triplicate in 30 mm culture dishes. Colonies were scored after a 7-day incubation. In some experiments, cells were grown in collagen in the absence of CSF 1 for up to 9 days; CSF 1 was added to the cultures in 150 pL Iscove X 1 at indicated times. Colonies were scored 7 days after addition of CSF 1. All colony assays were repeated at least three times.
Apoptosis studies. Apoptotic cells are found in culture supernatants by virtue of their reduced adherence; only a small percentage of adherent cells show DNA fragmentation. Thus, DNA fragmentation studies can be made only on cells found in culture Supernatants:
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From unfortunately, once detached, BAC 1.2F5 cells die very rapidly and only very small amounts of DNA, often totally degraded, can be extracted. Because of these technical difficulties, apoptosis studies were performed with colony assays, not DNA fragmentation studies, after checking that heat shock, mitoxantrone, H202, and CSF 1 withdrawal, indeed, induced apoptotic death in BAC 1.2F5 cells. Heat-shock studies were performed as follows: suspensions of 1,000 cells in lscove X I were incubated in triplicate at 42°C for 15 minutes and plated in collagen mixture in the presence of 10% L929 CM. For the other apoptosis studies, cells were incubated for 90 minutes at 37°C in the presence of IO-' mom or molL mitoxantrone, washed once, or with 0.25 mmom or 0.50 mmom H202, and 1,000 cells plated in collagen with 10% serum and 10% L929 CM, as described above. Cultures were incubated at 37°C and colonies scored after 7 days. Assays were repeated at least three times.
Cell cycle analysis. In the first set of experiments, cells were grown in the presence of 10% of L929 CM until semiconfluence, split 1 to 5 , grown overnight in the presence of 5% L929 CM and used for cell cycle studies the next day. In the second set of experiments, cells were grown to semiconfluency in the presence of L929 CM, then washed twice to remove CSF 1 and incubated for 24 hours without CSF 1. CSF 1 (5% L929 CM) was then reintroduced for 15 to 18 hours and cell cycle analyzed 24 hours later. Before cytometry analysis, cells were washed twice with RPM1 1640 and serum and stained as described by Vindelov?' Flow cytometry was performed using an ATC 3000 cell sorter (Briiker-Odam-France, Wissenbourg).
Fractions of cells in GI, S , or G2 + M phase were determined with triplicate samples using Baisch's mathematical model. Experiments were repeated three times.
RESULTS
Expression of ai2 mutants in BAC 1.2F5 cells. G418-resistant BAC 1.2F5 cells were obtained for each (yi2 construct. Cell morphology was slightly different for BAC 1.2F5 cells expressing ai2-G204A: these cells were rounded and apparently less adherent than control cells. The level of A ai2 -CORRE AND HERMOUET membrane expression of ai2 proteins in macrophages is high; in pools of ai2-Q205L and ai2-G204A-infected cells, levels of ai2 expression were roughly similar to the level expressed in vector-infected cells (Fig IA) . ai2 mRNA expression in infected BAC 1.2F5 cells was studied: the sizes of mRNAs detected by the ai2 probe were approximately 2.4 to 2.6 kb for endogenous (yiZ and 5.0 to 5.5 kb, and 10 kb for transfected ai2-Q205L and ai2-G204A (Fig IB) . Therefore, in infected BAC 1.2F5 cells, mutant ai2 subunits are expressed, but the total amount of ai2 subunits is nearly unchanged.
CSF l-dependence. After G418 selection, clones of (yi2-infected BAC 1.2F5 cells were grown in the presence of serum, but without CSF 1. Expression of ai2 mutants did not induce CSF 1 independence in BAC 1.2F5 cells: none of the a,-infected clones was able to proliferate in the absence of CSF 1.
Growth characteristics of ai2-infected BAC 1.2F5 cells in response to CSF 1. When BAC 1.2F5 cells were grown in monolayers in the presence of 5% L929 CM (Fig 2) , cells expressing the activated form of ai2 grew faster than vectorinfected cells. To the contrary, cells expressing the dominant negative mutant of aiZ grew very slowly. Doubling times were respectively: 52 hours (vector-infected cells), 46 hours (ai2-Q205L infected cells), and 65 hours (ai2-G204A infected cells). Similar results were observed in the presence of 1% or 10% L929 CM (data not shown). To explain the difference in proliferation rate and doubling time, we studied the percentage of infected BAC 1.2F5 cells in G1 phase in the presence of 5% L929 CM ( Table 1) . We found that the percentage of cells in G1 phase was 57.4% for control cells, 50.8% for ai2-Q205L-expressing cells, and 59.6% for ai2-G204A-expressing cells was 30.9% for control cells and 39.4% for ai2-Q205L expressing cells. Therefore, the duration of G1 phase was 25.4 hours for control cells, 19.1 hours for aiz-Q205L expressing cells, and 33.1 hours for ai2-G204A expressing cells. The duration of S + G2 + M phases was also longer for ai2-G204A expressing cells (31.9 hours) than for control cells and ai2-Q205L-expressing cells (26.6 hours and 26.9 hours, respectively).
Clonogenic assays were performed in the presence of variable concentrations of purified human recombinant CSF 1 (Table 2) . No colony formation was observed in the absence of CSF 1, no matter which ai2 mutant was expressed in BAC Doubling times were determined from growth curve slopes (Fig 2) . 1.2F5 cells. BAC 1.2F5 cells expressing aiz-Q205L formed almost twice as many colonies as control cells at low concentrations of CSF 1, confirming that aiz-Q205L expressing BAC 1.2F5 cells require less CSF 1 for their proliferation. The size of the colonies obtained with ai2-Q205L-expressing cells was also significantly larger. When high doses of CSF 1 were used, clonogenicity of aiz-Q205L cells remained the highest, but the difference with control cells narrowed. To the contrary, clonogenicity and size of colonies were reduced with all concentrations of CSF 1 for ai2-G204A cells; at high concentrations (2,000 UlmL), the number of colonies formed by ai2-G204A-expressing cells was still about half the number obtained with control cells. BAC 1.2F5 cell survival in the absence of CSF 1. After infection and G418 selection, several clones expressing aiz-Q205L and ai2-G204A were maintained without CSF 1. Five clones infected with vector alone and 10 clones expressing aiz-Q205L were tested (Table 3 , part A). None of the clones infected with vector alone remained viable after day 5. All clones expressing ai2-Q205L remained viable until day 10; eight of these clones survived until day 35, and three until day 55. These cells survived without dividing. Clonogenic assays were performed on cell pools with delayed addition of purified CSF 1 (Table 3 , part B). In these assays, cells were maintained for 3, 6, or 10 days without CSF l, then 500 u/mL of CSF 1 were added, and colonies were scored 7 days after CSF 1 addition. After 3 days of CSF 1 withdrawal, clonogenicity was reduced by 40% for vector-infected cells, by only 12% for ai2-Q205L-expressing cells, and by 53% for cells expressing ai2-G204A. Six days after CSF 1 withdrawal, ai2-Q205L cells' clonogenicity (14.6%) was almost five times the cionogenicity of control cells (3.0%); clonogenicity of ai2-G204A cells was only 1.6%. In other experiments, cells were grown in monolayers to semiconfluency in the presence of CSF 1, then washed and maintained with RPM1 and serum only. A typical experiment is shown on Fig 3. BAC 1 Part A Immediately after G418-selection, ai2-Q205L expression was verified by Western and Northern blotting and BAC 1.2F5 clones were maintained without CSF 1 in 100-mm Petri culture dishes with medium replaced twice a week. Part B: 1,000 BAC 1.2F5 cells expressing mutated a,2 were plated in collagen in triplicate without CSF 1. A total of 500 U of purified human recombinant CSF l was added immediately (O), or 3, 6, or 10 days later. Colonies of more than 30 cells were scored 7 days after addition of CSF 1. Results are the mean 2 SEM.
Fractions of cells in G1
2. To the contrary, most BAC 1.2F5 cells expressing a,2-Q205L remained viable for more than 7 days; 50% of cell viability was lost only after day 7.
Protection from apoptosis. BAC 1.2F5 cells, like other growth factor-dependent cells, die by apoptosis when their growth factor is withdrawn (Fig 4) . Mutated a,? subunits have opposite effects on BAC 1.2F5 cell survival in the absence of CSF l, ie, on apoptosis induced by withdrawal of CSF 1. We investigated if expression of mutant aiz proteins could also interfer with apoptosis induced by other methods. Response to apoptotic agents was studied using clonogenic assays of BAC 1.2F5 cells pretreated with Hz02, mitoxantrone, or submitted to heat-shock (see Materials and Methods). Results are shown in Table 4 . Cells expressing ai2-Q205L resisted to apoptosis induced in G1 phase (heatshock or H202 better than control cells; loss of viability and clonogenicity in these conditions was more important in cells expressing ai2-G204A than in control cells. However, expression of ai2-Q205L did not protect BAC 1.2F5 cells from apoptosis after exposure to mitoxantrone, a drug-inducing cell death in S phase or after, while ai*-G204A-expressing cells appeared protected.
DISCUSSION
In this study, we show for the first time that heterotrimeric G proteins modulate signal transduction of hemopoietic cytokines: G,? proteins can up or downregulate proliferation and survival signals of CSF 1, a cytokine with tyrosine-kinase receptors. Expression of Gi2 proteins is upregulated during differentiation of myeloid cells into macrophages. Thus, macrophages have very high levels of Gi2 proteins, making overexpression of G,2 mutants difficult in these cells: in transfected BAC 1.2F5 cells, mutant Gi2 expression represented probably no more than 50% of all Gi2 proteins. Nonetheless, as observed in other cells,25 this level of expression was sufficient to significantly alter G , 2 '~ function in cell growth regulation. The c~,~-G204A mutant, once coupled to P-y subunits liberated by endogenous ai?, does not dissociate.
In stable transfections, this means that endogenous G,* is progressively and constantly replaced by inactive G204A-Gi2; replacement of 40% or 50% of endogenous GI? by G204A-Giz is sufficient to inhibit significantly G , 2 '~ metabolic pathways, ie, to reproduce PT effects on macrophage proliferation.
CSF l stimulates cell proliferation by making cells go into G1 phase, then stimulate GUS transition and G1 exit; CSF 1 also regulates the duration of S phase." When they express a constitutively activated form of Gi2, BAC 1.2F5 cells remain strictly dependent from CSF 1 for their survival and proliferation, but the length of G1 phase is reduced and the cells become responsive to very low concentrations of CSF 1. To the opposite, inhibition of G,z function in BAC 1.2F5 cells results in partial loss of adherence, reduced proliferation potential, lengthened G1 and S phases, and doubling time, which cannot be overcome by high concentrations of CSF 1. Besides cell proliferation, hemopoietic cytokines promote cell survival, or protection from apoptosis. BAC 1.2F5 cells expressing a~-Q205L survive longer in the absence of CSF 1, and this ability to delay programmed cell death protects them from apoptosis induced by other methods, such as heat shock or H202. Apoptosis induced by growth factor deprivation, heat shock or H202, occurs after arrest of the cells in G1 phase."' Apparently, in ai2-Q205L-expressing BAC 1.2F5 cells, G1 arrest does occur, because cells survive without dividing in the absence of CSF 1, and eventually die if deprived of CSF 1 for more than 7 days. However, activation of Gi2 does not protect cells from apoptosis induced by mitoxantrone, a drug that induces cell death in S phase or after."2s44 Expression of ai2-Q205L probably makes cells more sensitive to mitoxantrone because of the short GI phase. On the contrary, cells expressing ai'-G204A have less ability to resist to apoptosis induced in G1 phase (by CSF 1 deprivation, heat shock, or H202) and their long G1 phase probably explains their resistance to a short exposure to mitoxantrone. We suggest that Gi2 exerts its protective effect on G1 phase-induced apoptosis by regulating G1 arrest: expression of ai2-Q205L seems to delay G1 arrest, while expression of a,-G204A seems to accelerate G1 arrest. However, once cell arrest in G1 or G2/M phase occurred, rapid activation of apoptosis is still possible in all aiz-infected BAC 1.2F5 cells.
Koyasu et aI6 showed that PT inhibition of IL-3-induced proliferation was associated with increased G1 phase and cell doubling time. Miller et al," described PT inhibition of Epo signal transduction and suggested that Gi2 orland Gi3 might be involved; Kesselring et all4 recently reported selective changes in Gi2 and Gi3 expression associated with erythroid differentiation. Our data provide the proof that Gi2 is the G protein responsible for the effects of PT on CSF 1-stimulated cell proliferation, and strongly suggest that Gi2 is also the G protein responsible for PT effects on signal transduction of other hematopoietic cytokines. More importantly, we show that inhibition of Gi2 function inhibits CSF l-signal transduction, even at the highest CSF 1 concentrations: therefore, it is likely that Gi2 regulates an effector that is also activated by the CSF 1 receptor and essential for its signal transduction. Again, because PT inhibits signal transduction of IL-3, IL-4, GM-CSF, and Epo receprole in the signal transduction of these hematopoietic cytokines. The effector regulated in BAC 1.2F5 cells by Gi2 and CSF 1 receptors, remains to be identified. Like most hematopoietic cytokine receptors, signal transduction of CSF 1 receptors includes p2lras. raf kinase, mitogen activated protein (MAP)-kinase, and at least one phosphotyrosine phosphatase.""' From studies concerning Gi2's role in the regulation of fibroblast proliferation, we know that PT inhibits, and that 07 subunits stimulate, MAP-kinase a~t i v i t y~.~' :
hence, Gi2's action on cell growth could result from modulation of MAPkinase activity. In fibroblasts, p2lras GTP-loading is inhibited by P T : * indicating that Gi2's effector acts upstream of p2lras. and not on MAP-kinase itself. Tyrosine phosphorylators,6.7.13.14 it is probable that Gi2's effector plays an important In summary, we showed that Gi2 is the G protein responsible for the effects of PT on CSF 1 -stimulated cell proliferation, and that the metabolic pathways regulated by Gi2 proteins and CSF 1 tyrosine-kinase receptors converge on a common effector necessary for the regulation of macrophage survival and proliferation. G,2 physiologic agonists and effectors in hematopoietic cells remain to be identified, and BAC 1.2F5 cell lines expressing mutant G,2 proteins should be useful tools in these studies.
